Life Sciences

Judge rules J&J and Janssen misled physicians

Pharma Compliance Alert, March 11, 2009

Johnson & Johnson and its Janssen Pharmaceuticals unit must pay West Virginia roughly $4.5 million for misleading the state’s physicians about the risks and benefits of the antipsychotic Risperdal and narcotic pain patch Duragesic, according to a release from State Attorney General Darrell McGraw.

In his decision, West Virginia Circuit Court Judge Martin Gaughan noted the FDA issued warning letters to the companies for their promotion of Risperdal and Duragesic.

Read more about Gaughan's decision against J&J and Janssen.

Most Popular